A Pilot Study on the Use of Gadopiclenol for Enhanced Cardiac MRI in Children with Congenital Heart Conditions: A self-controlled, non-randomised, open-label study to compare the image quality and diagnostic performance of gadopiclenol versus gadoterate meglumine
This research is a pilot study, which means it's one of the first times this new approach is being tested. It focuses on children with heart conditions that they've had since birth, such as cardiomyopathy or Tetralogy of Fallot. Doctors use MRI scans to get detailed pictures of the heart. To make these pictures even clearer, they often use a special dye called a contrast agent. This study is testing a new contrast dye called gadopiclenol against one that's already in use, called gadoterate meglumine. The main goal is to see which dye helps them get better quality images of the heart muscle and can better detect any scarring. This information will help doctors diagnose and treat these heart conditions more effectively in the future.
At a glance
What is this study about?
Imagine doctors need to take a really detailed picture of a child's heart, especially for conditions they've had since birth. They often use a special scan called an MRI. To make these pictures super clear, they use a special liquid, called a contrast dye, which is given before the scan.
This study is looking at two different contrast dyes. One is a new dye called gadopiclenol (also known as Elucirem), and the other is a dye that doctors have been using for a while, called gadoterate meglumine (also known as Dotarem). The main purpose of this research is to compare these two dyes to see which one helps doctors get better quality images of the heart. They want to see which dye makes it easier to spot problems, like scarring in the heart muscle, and which helps them feel more confident in their diagnosis.
By finding out which dye is better, doctors can improve how they diagnose and manage heart conditions like cardiomyopathy, Tetralogy of Fallot, or other serious heart problems that children are born with. This could lead to more accurate treatment plans and better care for young patients in the future.
Key takeaways
- This study compares two contrast dyes for heart MRI scans in children.
- It aims to find which dye gives clearer images for congenital heart conditions.
- Participation involves MRI scans and receiving contrast dyes.
- The study is for people aged 18 and over with specific congenital heart problems.
- It could help improve future diagnosis and care for children's heart conditions.
Who may be eligible?
This study is open to both boys and girls who are 18 years old or older. The specific age range starts at 18, so children younger than this would not be able to join.
Participants must have certain heart conditions that they were born with. These include cardiomyopathy (a problem with the heart muscle), Tetralogy of Fallot (a specific group of heart defects), or other serious and complex congenital heart diseases.
The research team will have specific medical criteria to decide if someone can take part. This ensures the study is safe and that the results are reliable. It's important to discuss your full medical history with the study team to see if you meet all the requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with cardiomyopathy, Tetralogy of Fallot, or a complex congenital heart disease?
- Are you able to have an MRI scan?
- Are you comfortable receiving contrast dye injections for your MRI?
- Are you able to attend several clinic visits for tests and scans?
What does participation involve?
If you decide to take part in this study, you will have a series of visits to the clinic. You'll undergo procedures like cardiac MRI scans, which are special detailed pictures of your heart. During these scans, you will be given one of two contrast dyes, either gadopiclenol or gadoterate meglumine, to help make the images clearer. Because this is a 'self-controlled' study, you might receive both dyes at different times to allow for a direct comparison within your own body.
Doctors will carefully assess the quality of the pictures taken and how well they can diagnose any heart problems using each dye. They will also collect blood samples and monitor your health closely throughout the study for any changes. The study will involve several appointments, some tests, and follow-up checks. The total time you'll be involved in the study will be explained in detail by the research team.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is a congenital heart condition?
These are heart problems that a person is born with. They can affect how the heart works.
Why do doctors use contrast dyes for MRI scans?
Contrast dyes make the images from an MRI scan much clearer, helping doctors see details in the heart more easily.
What is the difference between gadopiclenol and gadoterate meglumine?
These are simply two different types of contrast dyes. This study is comparing them to see which works best for cardiac MRI.
Will I know which dye I’m getting?
Yes, this is an 'open-label' study, meaning both you and the study team will know which dye you are receiving.
What does a 'Phase III' study mean?
Phase III studies are usually the final step before a new treatment or approach is considered for wider use, confirming its effectiveness and safety.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.